Quite a step up in volume, on a rising share price. It may relate to some of our newer posters now getting involved, and if so welcome to the club (but it's still a small club, unknown by the broader market).
My feeling is that this momentum is only the beginning of a considerably greater move upwards, and with still 2 months from an expected positive announcement.
I will say that recently I sought the comments of long termers in NEU, to ask what their strategy going in to the expected FDA decision on its drug that relates to Rhetts syndrome. To be expected there were some that sold a portion of shares (at a profit) as part of their money management. But there were a number who put it on the line, by holding all shares in readiness and expectation of a positive outcome.
I don't consider myself as an aggressive risk taker, but I can confirm I have no intention of selling even 1 share before the outcome of the SOLVE-CRT trial, and again will hold all going to the FDA approval thereafter. IMO if the efficacy and safety endpoints are achieved there is no way the FDA will knock WISE off at that stage - as much as anything FDA has been very supportive with this expedited process for EBR.
Add to My Watchlist
What is My Watchlist?
